BenAI Engine is the foundation of our end-to-end drug discovery offering
It uses machine learning to unlock the power of the vast and expanding biomedical data landscape to generate new insights into the underlying causes of disease.
DATA SOURCES
Generating a 360° view of disease biology
Massive quantities of biomedical data are generated daily, yet scientists currently only use a fraction of the information available to understand the causes of diseases and propose new treatments.
We provide scientists with a holistic view of disease biology by integrating as much data as possible across domains and diverse data types, including ’omics, molecules, experimental data, literature, pathology and biological systems. By bringing together these disparate, complex data sources, we break down silos across therapeutic areas to connect shared mechanisms across diseases.
AI FOUNDATIONS
Uncovering novel insights using domain specific AI models
We have developed, hand-in-hand with scientists, domain specific AI models that generate proprietary insights backed up by scientific evidence across the entire drug discovery and development process. These AI models are the foundation of our End-to-End drug discovery offering.
DATA FOUNDATIONS
Turning data into knowledge
Our automated, custom-engineered processing pipelines make this disparate data accessible and useful for scientific enquiry. Machine learning models extract biomedical entities, such as genes, diseases, drugs, processes and cell types, and infer relationships that capture how these entities interact in a human system.
These relationships form a network of contextualised scientific facts – providing a proprietary integrated view of biomedical data that supports discovery and decision making.